Brandon Sim - 02 Feb 2026 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Feb 2026, 21:37:01 UTC
Prior SEC filing
07 Mar 2025
Next SEC filing
08 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kathy Diep, as Attorney-in-Fact

Key filing fact

Brandon Sim filed Form 4 for Astrana Health, Inc. (ASTH) on 03 Feb 2026.

Key facts

  • This page summarizes Brandon Sim's Form 4 filing for Astrana Health, Inc. (ASTH).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Feb 2026, 21:37.

Change

  • Previous filing in this sequence was filed on 07 Mar 2025.
  • Current net transaction value: +$495,802.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001813532 Primary reporting owner

Sim Brandon

Relationship
CEO and President
Address
C/O ASTRANA HEALTH, INC., 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA
Signature
/s/ Kathy Diep, as Attorney-in-Fact
Signature date
03 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASTH transaction

Common Stock

Options Exercise

Transaction value
$495,802
Shares
+21,334
Change %
+2.1%
Price
$23.24
Shares after
1,045,329
Date
02 Feb 2026
Ownership
Direct
Footnotes
F3, F4
ASTH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
258,824
Date
02 Feb 2026
Ownership
By Sim Family Irrevocable Trust 2021
Footnotes
F1
ASTH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
392,816
Date
02 Feb 2026
Ownership
By Brandon Sim 2020 Irrevocable Trust
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ASTH transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-21,334
Change %
-100%
Price
$0.000000
Shares after
0
Date
02 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
21,334
Exercise price
$23.24
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These securities are held by the Sim Family Irrevocable Trust 2021. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F2

These securities are held by the Brandon Sim 2020 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F3

Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 29,919 shares, which will vest on June 27, 2026; and (ii) 51,309 shares, which will vest in three equal semi-annual installments, beginning March 31, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 75,433 restricted stock units, which will vest in five equal semi-annual installments beginning on April 2, 2026; and (ii) 127,437 restricted stock units, which will vest in seven equal semi-annual installments beginning on March 5, 2026.

Footnote F4

Includes 1,420 shares acquired under the Issuer's Employee Stock Purchase Plan.

Footnote F5

These stock options were fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .